AUGUST 30, 2021 www.sdbj.com 37

JESSICA ALEXANDER KATHERINE ATKINSON HAI BLANKINSHIP LORNA BRIDDICK KATE BRODERICK AMY BUTLER JENNIFER CASE Lundbeck Pharmaceuticals Truvian Longfellow Real Estate Partners Brizzey INOVIO Pharmaceuticals Thermo Fisher Scientific New Leaf Biofuel

ATHENA JAMI RACHEL FORD HUTMAN PAMELA GARDNER LISA HAILE SUSIE HARBORTH DENISE HARTSELL COUNTOURIOTIS, M.D. DEBRANGO-PALUMBO Ford Hutman Media Biotech Vendor Services, Inc. DLA Piper Breakthrough Properties ResMed Turning Point Therapeutics Foundation Medicine Inc. Women of Influence Life Sciences 2021 SIBYLLE HAUSER MOLLY HE, PHD STACEY HERRICK SARAH HIBBARD Richtr Financial Studio Element Biosciences Catalent Pharma Solutions Snell & Wilmer

NATALIE HOSEA NEHA KRISHNAMOHAN MYPHUONG LE KRISTINA MANVELIAN MAGDA MARQUET KATHY MCGEE JILL MCGRADY, PHD Takeda California, Inc. Kinnate Biopharma Microtek ACADIA ALMA Life Sciences Avita Medical Great Ecology Pharmaceuticals Inc.

TRACY A. MURPHY PADMA NAGAPPAN KARRI NOVAK SAUNDRA PELLETIER ALLY PERLINA RUTH PETERSEN EVELYNE PLOQUIN IQHQ Civilian Suffolk Evofem Biosciences CureMatch, Inc. Biosero, Inc. Biosero, Inc.

TANYA RUSSELL ANDREA SALAZAR NOEL SAUER CHRISTINA TOWERS, LEAH VILLEGAS GAYANI WEERASINGHE SAMANTHA WYNNS Biosero, Inc. Cibus PHD Microtek Law Offices of Gayani R. The Great Basin Institute Salk Institute Weerasinghe for Biological Studies 38 www.sdbj.com AUGUST 30, 2021

Women of Influence Life Sciences 2021

JESSICA ALEXANDER KATHERINE ATKINSON HAI BLANKINSHIP Principal Scientist Senior Vice President, Commercial Sales, Service, and Support Regional General Manager, Property Management

Dr. Jessica Alexander is Principal Scientist and Biology Project Leader A life science industry veteran, Katherine Atkinson is Truvian Hai Blankinship currently manages the daily operations of Longfellow for MAGL inhibitor discovery projects at Lundbeck La Jolla Research Sciences' Senior Vice President of Commercial Sales, Service Real Estate Partners' San Diego portfolio which consists of over 1 million Center. Under her leadership, the LLJRC team has discovered differen- and Support. Atkinson has more than 20 years of experience in square feet of life science space. Since joining Longfellow in 2019, her tiated MAGL inhibitors that are at various stages of development in the the healthcare and life sciences industries. Prior to joining Tru- responsibilities include day-to-day operations of the properties across quest to restore brain health. Alexander keeps the focus on patients, vian, Atkinson served as Epic Sciences' chief commercial officer, various sectors such as acquisition, leasing, construction, prepara- building a sense of community by organizing LLJRC teams to participate where she identified new strategic business opportunities and tion of annual operating and capital budgets, financial reporting, and in walks and runs to raise money and awareness for brain diseases. deepened existing strategic partnerships. Before Epic, Atkinson tenant relations. Blankinship has been an instrumental part of the San Prior to joining Lundbeck, she was Principal Scientist at Abide Ther- was Vice President of Business Development and Strategic part- Diego market's portfolio expansion to over 1 million square feet, the apeutics, a biotech where she focused on identifying and advanc- nerships at Edico Genome. oversight and operations to the West Coast operational growth, and ing targets from the serine hydrolase family. Alexander is actively Previously, she held roles of increasing responsibility at Illumina, formation of Longfellow's culture in new, emerging California markets. involved in the San Diego Chapter of Women in Bio and their mission including as Commercial Director of Global Channel Partners and Blankinship has taken a focused interest in the highly specialized life of supporting women in the field of life sciences from classroom to Director, Global Channel Partners, LATAM & Inside Sales, Demand sciences space, working closely with tenants to provide best in class boardroom, promoting careers, leadership and entrepreneurship. She Generation and Product Care Teams. Atkinson's previous expe- property operations and management for small and big life science served first as Communications Chair and currently is Co-Vice Chair rience also includes leadership roles at Fisher Scientific, Ther- tech companies. She has her Real Property Administrator designation of this dynamic chapter. mo Fisher and Beckman Coulter. She holds a B.A. in Broadcast through BOMA and is also an active member of NAIOP, BIOCOM, and Journalism and Public Speaking from the University of Houston. the California Life Sciences Association.

LORNA BRIDDICK KATE BRODERICK AMY BUTLER Managing Partner Senior Vice President R&D President, Biosciences Division

Lorna Briddick is a managing partner of Brizzey LLC. She has 19 years Dr. Kate Broderick, INOVIO's Senior Vice President of Research Amy K. Butler serves as the Division President of Biosciences at of experience in leading clinical supply chain business process de- and Development, works in INOVIO's research labs in San Diego, Thermo Fisher Scientific. Prior to her current role, she led the Cell sign, optimization, and training. She started her career as a consul- focusing on the development and enhanced delivery of a range Biology business, including efforts to support Cell and Gene Ther- tant to Pfizer and led the optimization of their clinical supply chain. of DNA medicines designed to prevent often deadly infectious apy customers. Butler has held multiple general management and She held operational roles of increasing influence, where she served diseases and cancers. She has authored and co-authored 60+ functional leadership roles at Thermo Fisher, including overseeing as the Schering Plough/Merck Global Clinical Supply Regional Lead to peer-reviewed articles. Her team regularly publishes and pres- Marketing & e-Business, Global Customer Care, and the Gene Ex- Latin America. Along with operational roles, Briddick led numerous ents their findings in leading scientific publications and at con- pression Profiling business unit. She joined Invitrogen, then Life initiatives to optimize clinical supply chain processes, implement ferences worldwide. She is a co-inventor on multiple patents Technologies, and now part of Thermo Fisher, in 2004. new technology/tools, and train new teams. She left Merck as a di- related to DNA vaccine delivery and serves as a principal inves- Prior to joining Invitrogen, Butler served as an engagement man- rector in 2013 and co-founded Brizzey LLC with two other partners, tigator on grants, awards, and contracts from leading govern- ager with McKinsey & Co. where she worked predominantly with where she has served as a managing partner for 7 years helping ment agencies and not-for-profit organizations. Dr. Broderick large pharmaceutical companies on R&D, sales and marketing more than 45 small to medium size companies with clinical sup- has helped the development of novel prototypes and designs of strategies. Prior to that, she was a developmental neuroscientist ply chain strategies and operational support. She has also served INOVIO's proprietary smart device CELLECTRA, which delivers at the Salk Institute. She obtained her doctorate in neuroscience Global Clinical Supply Group Planning Committee and is a regular the company's DNA medicines directly into cells in the body. In from the University of Pennsylvania. Additionally, she sits on the presenter on current topics affecting the industry. 2018, Dr. Broderick was named Business Woman of the Year by Alliance for Regenerative Medicine Board of Directors. San Diego Business Journal. In 2021, she was named one of In Vivo's Rising Leaders. AUGUST 30, 2021 www.sdbj.com 39

WOMEN OF INFLUENCE IN LIFE SCIENCES 2021

Congratulations, Andrea, Ruth, and Evelyne! Each of you influences Life Science and Biotech with unique and incredible expertise. Your integrity and grit are an asset to our team.

RUTH EVELYNE PETERSEN PLOQUIN Director of Marketing Solutions Architect

ANDREA SALAZAR Chief Operating Officer

Making an impact on mission-critical discoveries

9560 Waples Street, San Diego, CA 92121 www.biosero.com 40 www.sdbj.com AUGUST 30, 2021

Women of Influence Life Sciences 2021

JENNIFER CASE ATHENA COUNTOURIOTIS, M.D. JAMI DEBRANGO-PALUMBO Founder, President & CEO President & CEO Senior Vice President, Client Services and Operations Jennifer Case is CEO of New Leaf Biofuel, a local company that collects Dr. Athena Countouriotis became president and chief executive Jami DeBrango-Palumbo is the SVP of Lab Operations & Client Ser- used cooking oil from 2,200 area restaurants and converts it to bio- officer and was named to the Turning Point Therapeutics board vices at Foundation Medicine, Inc. She is a dynamic leader who diesel, an eco-friendly alternative to diesel fuel. The fuel is delivered to of directors in September 2018. She has broad oncology biotech served as the VP of Sequencing Operations. Prior to that she was customers throughout Southern California including truck stops. Bio- leadership experience, guiding multiple development programs Vice President, Roche Global Regulatory Complexity Management diesel displaces diesel fuel, thus reducing greenhouse gas emissions to approval. Her experience includes large and small molecule Program, a program focused on simplifying a complex network of by 80%-allowing us all to breathe easier. Case oversees all aspects of therapeutics in hematologic and solid tumor indications, with global regulatory processes, which spanned more than 120 coun- the company, including operations, client relationships, commercial multiple regulatory approvals in the U.S. and Europe. tries. She joined in 2005 with the Biogen-Idec acquisi- drivers, lobbying, and more. She joined Turning Point Therapeutics in May 2018 as executive tion, and has since served in roles of increasing responsibility, which She has raised over $6 million for New Leaf through various grants to vice president and chief medical officer to advance the clinical span from HR, Facilities, Engineering, Supply Chain Operations and the California Energy Commission and Air Resources Board. Drawing development of repotrectinib. Dr. Countouriotis also serves on Safety, Health and Environment (SHE). on her experience in the legal field, Case coordinated with each of the board of directors of Iovance Biotherapeutics and Passage She has continued to take on senior leadership roles; her career jour- the city and County agencies to ensure compliance with all land use Bio. She earned a Bachelor of Science degree from the Univer- ney includes roles such as Global Head of Project Management and and environmental regulations. When she is not working on strategy sity of California, Los Angeles, and an M.D. from Tufts University Process Excellence, Pharma Technical Operations Biologics and Pres- with her management team, she is in Sacramento or Washington DC School of Medicine. She received her initial medical training in ident and Site Head for Roche Carolina Inc., a PT Small Molecules Site. advocating for policy that will strengthen the renewable fuels indus- pediatrics at the University of California, Los Angeles, and addi- try and combat climate change. tional training at the Fred Hutchinson Cancer Research Center in the Pediatric Hematology/Oncology Program.

RACHEL FORD HUTMAN PAMELA GARDNER LISA HAILE CEO and Founder, Ford Hutman Media President and CEO Partner

Rachel Ford Hutman is a media relations specialist and global health- In 2003, Pamela Gardner, founded Biotech Vendor Services, Inc. Dr. Lisa Haile has been a patent attorney for more than 30 years, care industry connector. In 2020, she founded Ford Hutman Media, (BVS) to assist bio-pharma companies and research institutes to representing eight Nobel Prize winners during her career. With a a global communications firm that specializes in media relations, streamline their vendor management and supply chain through Ph.D. in Microbiology from Georgetown University Medical School thought leadership and executive visibility to life science compa- customized scientific, clinical and manufacturing, and supplier and three-years of post-doctoral studies focused on the biology nies in the U.S. and Europe. The firm has worked with Medtronic, diversity events. BVS has held over 2,500 events and gained an of cancer at the Sanford Burnham Medical Research Institute, Dr. Illumina, Komodo Health, HLM Venture Funds, Blueprint Medicines, impressive roster of over 1,000+ nationwide clients that include Haile assists clients with protecting life-saving diagnostics and Section 32 and Pacific Biosciences to name a few. Starting her ca- many of the top bio-pharma companies and suppliers. therapeutics. Her technical experience includes molecular biolo- reer as a reporter at The North County Times, she excels at working She has created a business model which allows her to further gy, immunology, cell biology, regenerative medicine, diagnostics, with the media to bring health stories to life while still making them integrate her "why" to empower women in science into her ex- and therapeutics. accessible to stakeholders. isting business. Having been in the science industry for 18 years Dr. Haile has served on the board of San Diego-based Biocom, the Named PRSA's PR Professional of the Year in 2011, Power Woman of she truly understands the issues that women are facing in sci- life sciences industry professional and advocacy organization, San Diego 2020, and a Distinguished Woman of San Diego in 2021, ence. Through her extensive network and loyal followers, she has for 15 years and in the role of General Counsel of Biocom for the she has built a reputation for her positive energy, creativity and hu- been able to catapult thought leadership on a nationwide scale past 10 years; serves as Chair of the Scientific Advisory Board for mor. She received her MA in communications at SDSU and her BA to people within the science industry. In 2019, she was award- San Diego-based DNA-SEQ Alliance; and is past- President of the in History from UMBC. ed the esteemed Athena Pinnacle Award in recognition for her San Diego Intellectual Property Law Association and of Athena, a achievements in making a significant difference in the lives of women's advocacy organization that fast tracks women in STEM women in STEM. through leadership development. AUGUST 30, 2021 www.sdbj.com 41

WOMEN OF INFLUENCE IN LIFE SCIENCE 2021

Congratulations to Jami DeBrango-Palumbo! As a strong female leader in the Life Sciences and Biotech industry for over 20 years, and with her passion for personalized healthcare, she has successfully paved a path for other aspiring women leaders in our industry. As the current Senior Vice President of US Operations and Client Services at Foundation Medicine, Jami strives to create a welcoming and innovative environment to help shape the future of cancer genomics. Her proud advocacy of servant leadership, as well her passion for DE&I have inspired her teams to bring their whole selves to work to transform cancer care.

For more information, visit: www.FoundationMedicine.com 42 www.sdbj.com AUGUST 30, 2021

Women of Influence Life Sciences 2021

SUSIE HARBORTH DENISE HARTSELL SIBYLLE HAUSER Executive Vice President, Business Operations Director, Product Marketing-Respiratory Care Strategic Advisor - Life Science Susie Harborth is Executive Vice President, Business Operations of As Director of North America Respiratory Care Product Marketing Sibylle Hauser's international professional career spans over 25 Breakthrough Properties where she oversees the firm's global prop- at ResMed, Denise Hartsell is responsible for the performance, years in global pharma including Boehringer Mannheim/Roche for erty operations platform. She has nearly 20 years of strategy and op- growth, and strategic direction of the respiratory care portfolio, 9 years, emerging biotech and global contract manufacturing at erations experience working with biotech and